samedan logo
 
 
 
spacer
home > ebr > spring 2008 > twenty-first century recruits
PUBLICATIONS
European Biopharmaceutical Review

Twenty-First Century Recruits

Talent acquisition today poses numerous challenges and opportunities for the life sciences industry. Pete Leddy of Invitrogen explores the changing world of pharmaceutical recruitment

Recruiting and retaining top employees is critical in order to secure a company’s continued success. As the biotechnology industry grows and expands, its talent needs rapidly increase, while the pool of qualified, diverse applicants is shrinking. This article explores the overall environment for talent acquisition (TA) in the life sciences and discusses why a solid TA plan is essential to achieving business goals. It will focus on a few of the challenges and experiences faced by the industry over the next few years, and will outline the resources that companies have at their disposal to attract and retain top talent.

BUSINESS GOALS IN THE SHORT AND LONG TERM

In developing a talent acquisition plan, companies must examine both long- and short-term business goals in order to align any hiring with those goals. What must a company accomplish in order to grow? The answer to that question will evidently vary significantly from company to company. Biotechnology and pharmaceutical companies poised to enter the clinic must be adept at planning clinical trials and working with regulatory agencies such as the US Food and Drug Administration (FDA) or the European Medicines Agency (EMEA). On the other hand, biotechnology tools companies seeking to offer ever more advanced technologies to life sciences researchers must continue to invest in newer technologies and build strong infrastructures to meet the demands of their customers.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Pete Leddy is Senior Vice President of Human Resources for Invitrogen, where he oversees global HR strategy and manages all aspects of the field. Prior to joining Invitrogen in 2005, Pete served as Vice President of Human Resources for the Americas operations of Dell Incorporated. He holds a PhD and a Master of Science degree in Industrial Organizational Psychology from the Illinois Institute of Technology.
spacer
Pete Leddy
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Restructure Announcement at Illingworth

As a rapidly growing company, Illingworth Research Group (Illingworth) has reflected on its goals, accomplishments and ambitious future growth plans. This has allowed us to consider opportunities for staff to explore their own growth and development possibilities within a rapidly changing landscape. With that in mind, Illingworth are announcing some significant and exciting changes to our organization. Illingworth remain committed to making patient involvement in clinical trials as stress free as possible and our strengthened management team and launch of our patient concierge service, PatientGO, in combination with global, mobile research nursing will ensure as many patients as possible have the chance to participate in the development of critical drugs, regardless of their geography or socioeconomic class.
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement